Skip to main content

Showing results for Indianapolis Campus

Early administration of anti-seizure medication may improve traumatic brain injury patient outcomes

Administering anti-seizure medications to patients after they experience a mild or moderate traumatic brain injury (TBI) could reduce their risk of having a seizure in the first seven days post injury, according to a new study by Indiana University School of Medicine researchers recently published in JAMA Neurology.

IU School of Medicine  |  Apr 15, 2024

12 years strong, Chuckstrong raises $1.5 million for IU cancer research

The 12th Chuckstrong Tailgate Gala on April 12 included former #12 Colts quarterback Andrew Luck and raised $1.5 million for research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

IU Simon Comprehensive Cancer Center  |  Apr 12, 2024

Five IU School of Medicine faculty honored among nation's top physician-scientists

Five Indiana University School of Medicine faculty have been recognized among the nation's top physician-scientists as 2024 members of the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).

IU School of Medicine  |  Mar 26, 2024

World-renowned researcher to continue innovative work in cancer therapy at IU

Pravin Kaumaya, PhD, a world-renowned innovator of vaccines for cancer treatment has joined the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the IU School of Medicine.

IU Simon Comprehensive Cancer Center  |  Feb 08, 2024

Cancer researcher Craig B. Thompson named 2024 Watanabe Prize winner

Pioneering cancer researcher Craig B. Thompson, MD, has been named the 2024 winner of the August M. Watanabe Prize in Translational Research.

IU School of Medicine  |  Feb 07, 2024

$3.9 million grant funds research on maternal influence in children’s allergy development

A five-year, $3.9 million grant will enable Indiana University School of Medicine researchers to explore how allergies and asthma may be passed from mothers to their children, presenting a better understanding of how allergies develop and paving the way for transformative approaches to allergy prevention and management. 

Repurposed drug offers new potential for managing type 1 diabetes

A recent study led by Indiana University School of Medicine in collaboration with the University of Chicago Medicine presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency.

IU School of Medicine  |  Nov 01, 2023

IU cancer center receives training grant for cancer drug discovery

he Indiana University Melvin and Bren Simon Comprehensive Cancer Center was awarded a prestigious grant to train the next generation of cancer drug discovery and development researchers.

IU Simon Comprehensive Cancer Center  |  Oct 10, 2023

IU cancer researcher receives $2.2 million grant for metastatic breast cancer research

A breast cancer researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.2 million grant from the National Cancer Institute to examine how certain immune cells support metastatic breast cancer development—and how to stop it.

IU Simon Comprehensive Cancer Center  |  Oct 03, 2023

IU School of Medicine expands point-of-care ultrasound training

Indiana University School of Medicine is expanding its training program for point-of-care ultrasound (POCUS) by investing in portable ultrasound systems for all students, residents, and fellows across seven specialties to use in curricula and patient care at the academic health center in Indianapolis.

IU School of Medicine  |  Sep 12, 2023